ArticleMolecules (Basel, Switzerland)2026

The Anti-SLAMF7 Antibody, Elotuzumab, Induces Antibody-Dependent Cellular Cytotoxicity Against CLL Cell Lines.

Dominik Kľoc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.